Research


Health, Wealth, and the 21st Century Cures Act

with Tomas Philipson and Andrew von Eschenbach, JAMA Oncology 2(2016), 17–18.

View abstract

TRC Networks and Systemic Risk

with Roger Stein, Journal of Alternative Investment 18(2016), 52–67.

View abstract

The Wisdom of Twitter Crowds: Predicting Stock Market Reactions to FOMC Meetings via Twitter Feeds

with with Pablo D. Azar, Journal of Portfolio Management 42(2016), 123–134.

View abstract

Q Group Panel Discussion: Looking to the Future

with Martin Leibowitz, Robert C. Merton, Stephen A. Ross, and Jeremy Siegel, Financial Analysts Journal

View abstract

Buying Cures Versus Renting Health: Financing Health Care with Consumer Loans

with Vahid Montazerhodjat and David M. Weinstock, Science Translational Medicine 8(2016), 327ps6.

View abstract

What Is An Index?

Journal of Portfolio Management 42(2016), 21–36.

View abstract

Law Is Code: A Software Engineering Approach to Analyzing the United States Code

with William Li, Pablo Azar, David Larochelle, Phil Hill, Journal of Business & Technology Law 10(2015), 297–374.

View abstract

Reply to “(Im)Possible Frontiers: A Comment”

with Thomas J. Brennan, Critical Finance Review 4(2015), 157–171.

View abstract

Funding Translational Medicine via Public Markets: The Business Development Company

with Sandra M. Forman, Monica Shilling, Grace K. Sweeney, Journal of Investment Management 13(2015), 9–32.

View abstract

Hedge Funds: A Dynamic Industry In Transition

with Mila Getmansky, Peter A. Lee, Annual Review of Financial Economics 7(2015), 483–577.

View abstract


Follow me on © 2017 Andrew W. Lo, MIT Sloan School of Management. All rights reserved.
Design by: Opus Design